Vestal Point Capital, LP Reports New 5.5% Stake in Immunocore Holdings plc

On May 15, 2026, Vestal Point Capital, LP filed a Schedule 13G disclosing a new ownership stake in Immunocore Holdings plc (IMCR). As of the event date on March 31, 2026, the reporting person beneficially owns 2,766,868 American Depository Shares (ADS), representing a 5.5% ownership interest in the company. This filing is made jointly by Vestal Point Capital, LP, acting as the investment manager for a specific fund and managed account, and Mr. Ryan Wilder, the Chief Investment Officer and Managing Partner of the firm. The shares are held in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The calculation of the ownership percentage is based on approximately 50,695,078 shares outstanding as of January 31, 2026. The reporting persons share voting and dispositive power over the reported securities. This position represents a significant new holding for Vestal Point Capital, LP, crossing the 5% regulatory disclosure threshold.